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The control of infectious diseases in pig farming is of great
importance from the point of view of animal welfare and economic
profitability. Pneumonias have been shown to cause the greatest
economic losses due to disease in pig houses. Prevention of
infections is the most humane way of fighting against disease.
Through the prevention of infections the use of antibiotics and thus
antibiotic residues can also  be avoided.
Mycoplasma hyopneumoniae, Actinobacillus
pleuropneumoniae and toxigenic Pasteurella multocida are the
most common and most detrimental respiratory pathogens of
swine, and they all may have periods of subclinical existence in
swine herds. Antibody assays of serum and colostrum have  great
potential for the diagnosis of subclinical infections. In this study
the ELISAs for M. hyopneumoniae antibodies were evaluated,  an
ELISA for A. pleuropneumoniae antibodies (12 serotypes) was
developed and the ELISA for P. multocida toxin was modified to
detect  antibodies against the toxin. The prevalence of M.
hyopneumoniae, A. pleuropneumoniae serotype 2 and P. multocida
toxin antibodies in disease-control breeding herds was determined
(193 herds, mean number of sows 30), as was the seroprevalence
of 12 different serotypes of A. pleuropneumoniae in Finnish
slaughter sows (n=700).
The serological ELISA tests for M. hyopneumoniae antibodies
were found to be specific and sensitive. The specificity of the
Chekit Hyoptest  was 98.0%, and that of the DAKO M.
2hyopneumoniae ELISA, 99.3% in this study. In a M.
hyopneumoniae conducted on disease-control herds, six herds out
of 185 were found to be infected. These herds were detected by
serological means at an earlier stage than  by traditional diagnostic
methods, i.e. by observing clinical signs and pathological findings
at slaughterhouses.
An ELISA for each of the 12 A. pleuropneumoniae serotypes
was developed. The phenol-extracted polysaccharide antigen was
found to be suitable for the assay. When specific antisera were
used, some weak cross reactions were found between  serotypes 1,
9 and 11, as well as between serotypes 6 and 8. In addition,
serotype 5(a) antiserum reacted with serotype 6 antigen. In the
case of field samples, the OD values of the samples reacting with
serotypes 9 and 11, 9 and 12, and 1 and 2 were correlated
(p<0.01), indicating antigenic similarities between these
serotypes or dual infection with different serotypes.  Antibodies
against various serotypes of A. pleuropneumoniae did not have
an  even distribution throughout Finland. Serotype 1, serotype 9
and serotype 12 antibodies were found most frequently in the
west, serotype 3  most frequently in the south-west and serotype
4 and serotype 6 antibodies in central Finland. Antibodies against
serotype 2 were distributed evenly throughout the country.
The disease-control herds were surveyed for A.
pleuroneumoniae serotype 2 because this  is the  serotype which  is
isolated from clinical A. pleuropneumoniae outbreaks in Finland.
This survey showed that A. pleuropneumoniae serotype 2 infection
is more widely distributed in disease-control herds than had been
3expected. Of the 154 herds tested, only 25 were totally free of A.
pleuropneumoniae serotype 2 antibodies. Previously, according
to the more established used disease-control methods, i.e.
observing clinical signs and slaughterhouse inspection, only 1 or
2 herds were found to be diseased each year. Despite this low
prevalence,  A. pleuropneumoniae infections of unknown  origin
interrupted progeny tests in stations that took piglets only from
disease-control herds.  It was concluded, therefore,  that the
prevention of A. pleuropneumoniae infections is more complicated
than was formerly considered. Clinical A. pleuropneumoniae
infections were rare, due to the variability in the virulence of A.
pleuropneumoniae strains.
An ELISA for the detection of P. multocida toxin antibodies
was developed on the basis of a commercial test for detecting P.
multocida toxin. Toxigenic P. multocida infection (progressive
atrophic rhinitis) was found in one of the disease-control herds.
The diagnosis was initially  made on serological grounds, and
thereafter confirmed clinically and bacteriologically. The diseased
herd included  imported pigs; these were the apparent source of the
infection. An eradication programme for athrophic rhinitis has
been successfully carried out in Finland for years.  P. multocida
toxin antibodies were not found in the disease-control herds,
comprised  only pigs  of Finnish origin.
Antibody assays appeared to provide a reliable diagnostic
methods at the herd level. In diagnosing the infection status of an
individual animal, assessment of  antibody status is not the most
effective method, because it takes at least 2 weeks after infection
4before the antibodies reach a measurable level.  On the other hand,
the animal continues to carry antibodies after it has expelled the
infectious agent. In M. hyopneumoniae infection, antibodies were
still detected  by ELISA one year after inoculation, even though
there were pathological lesion in the lungs and mycoplasmas were
not detected (Bereiter et al. 1990).   As herd tests, the antibody
assays are perfect diagnostic methods for disease-control programs
(Zimmermann and Tschudi 1989).  In this study the sensitivity
appeared to be close to 100%. As a result of these studies,  M.
hyopneumoniae antibody assays were included in the national
disease-control program, and P. multocida toxin antibody assays
are now required from herds applying for inclusion in the program.
 According to the serological data available, A.
pleuropneumoniae infections in Finnish Pig Health Scheme herds
were so frequent that freedom from this agent could not be
demanded. Most of the infections seemed to be mild, without any
clear clinical signs. A. pleuropneumoniae has also spread within
herds included in disease-control programs in other countries, and
other methods for A. pleuropneumoniae disease control are
therefore still required.
5List of original articles
The present thesis is based on the following original articles,
referred to in the text by the Roman numerals I to V.
I Levonen, K. Detection of enzootic pneumonia in swine herds
using an enzyme-linked immunosorbent assay (ELISA) from
sow colostrum. Res. Vet. Sci., 1994, 56: 111-113.
II Levonen, K., Sihvo, E and Veijalainen, P. Certification of
enzootic pneumonia in swine herds  with two enzyme-linked
immunosorbent assays (ELISA). J.Vet .Diagn. Invest, 1999,
11: 547-549.
III Levonen, K., Veijalainen, P., and Seppänen, J.  Actinobacillus
pleuropneumoniae serotype 2 antibodies in sow colostrum in
Finnish pig health scheme herds. J. Vet. Med. B., 1994, 41:
567-573.
IV Levonen, K., Veijalainen, P., and Seppänen, J.  Antibodies
against 12 serotypes of Actinobacillus pleuropneumoniae in
Finnish slaughter sows. J. Vet. Med. B., 1996,  43: 489-495.
V Levonen, K., Frandsen, P.L., Seppänen, J., and Veijalainen, P.
Detection of toxigenic  Pasteurella multocida infections in
swine herds by assaying intibodies in sow colostrum.  J.Vet.
Diagn. Invest., 1996, 8: 455-459.
6Introduction
During the last three decades pig production has intensified
dramatically. The increase in herd size sets serious demands for
the control of infectious diseases. In several surveys infectious
pneumonias  have been shown to cause the greatest economic
losses due to diseases in pig houses (Christensen and Mousing
1992, Straw et al. 1990). The spread of infectious diseases has
led to the wide use of antibiotics as food additions. There is
widening consumer concern about this kind of production
method (Aarestrup et al. 1998).  Although skilful management,
proper housing and balanced feeding improve disease resistance,
there are a number of infectious diseases which can also affect
pigs in favourable conditions.
Fortunately, the structure of pig production allows many
infectious diseases to be totally eliminated from pig herds.
Elimination of infectious agents can be successfully achieved
only if the agent in question can be accurately identified, the
epidemiology pattern of the disease is known,  and the spreading
pathways can be effectively eliminated.
The virulent and easily transmissable diseases, which
endanger human health or can ruin the economic outcome of pig
farms, are controlled by government and EU programs. In
addition to these diseases, there are a number of other diseases
which harm the well-being of pigs and reduce the profitability of
pig farming. In many countries, including Finland, voluntary
disease-control programs for breeding herds have been
7introduced. The Finnish Pig Health Scheme was established in
1963 (Schulman 1988), when 35 herds with the highest breeding
value were included in the scheme. In 1984 the control
programme was expanded and all the 200 active breeding herds
joined the scheme. The diseases controlled were enzootic
pneumonia (Mycoplasma hyopneumoniae), catarrhal pleuritis and
pneumonia (Actinobacillus pleuropneumoniae), progressive
atrophic rhinitis (toxigenic  Pasteurella multocida), swine
dysentery (Serpulina hyodysenteriae) and Clostridium
perfringens type C enteritis of new born piglets.
The diagnostic methods used in the Finnish Pig Health
Scheme initially consisted of farm visits by a veterinarian and
inspection of organs and carcasses in slaughterhouse, and mix-
match control in progeny testing stations that receive piglets only
from the herds participating in the scheme.
The old screening methods have been  found to be
insufficient for disease control. More valid methods were called
for by the local controlling veterinarians, who needed a good
reference system for diagnosis. Serology was reported to be a
promising diagnostic means for detecting subclinical diseases in
breeding herds (Nicolet 1988, Nielsen 1988). In Switzerland and
Denmark, serology has been successfully applied as a part of
their disease-control programs (Nicolet 1988, Nielsen 1988). The
application of enzyme-linked immunosorbent assays for the
detection of antibodies dramatically increased the utilisation of
serological methods in diagnostic laboratories during the 1990's.
The assays were considered to be sensitive enough for the
8measurement of weak immunoreactions typical of progressive
atrophic rhinitis and enzootic pneumonia. The Finnish Ministry
of Agriculture and Forestry decided to provide funds for the
present study, the object of which is  to develop and validate
ELISAs for the control programmes  of the Finnish Pig Health
Scheme.
91. Review of the literature
1.1 The role of diagnostics in disease-control
programs in pig farming
Contagious diseases have a negative effect on the well being of
pigs and the economic outcome of pig farms.  Therefore,
disease-control programs have been introduced on a voluntary
basis in several countries. The Finnish Pig Health Scheme was
introduced by the Ministry of Agriculture and Forestry in 1963,
and the Scheme has subsequently gained constantly growing
significance.
Adequate diagnosis is of crucial importance in disease-
control programs. The diagnostic methods adopted by the
Finnish Pig Health Scheme were long established (Keller 1976,
Goodwin 1977). The herds participating in the scheme were
inspected every three months by the local official veterinarian.
Carcasses and organs of five pigs per herd were inspected in
slaughterhouses twice a year. In addition, the progeny testing
stations, which take piglets only from disease control herds,
served as a mix-match control. The diseases of concern were
enzootic pneumonia (Mycoplasma hyopneumoniae), catarrhal
pleuritis and pneumonia (Actinobacillus pleuropneumoniae),
progressive atrophic rhinitis (toxigenic Pasteurella multocida),
swine dysentery (Brachyspira hyodysenteriae) and Clostridium
perfringens type C enteritis of new-born piglets. Routine
laboratory testing was not included either in the original scheme or
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the pig health scheme as renewed in 1984. Suspected disease
outbursts were confirmed by bacterial cultivation or by typical
pathological findings from slaughtered pigs.
M. hyopneumoniae, A. pleuropneumoniae, P. multocida
and B. hyodysenteriae infections may exist subclinically in pig
herds (Nicolet 1992, Ross 1992). These infections have spread
within disease-control herds in other countries (Nielsen 1988).
Subclinical infections were also suspected to occur in the Finnish
Pig Health Scheme herds following the finding that M.
hyopneumoniae and A. pleuropneumoniae caused epidemics in
closed progeny testing stations rearing piglets produced by the
Health Scheme breeders. Furthermore, doubt has been expressed
about  the efficiency of the traditional methods used for
diagnosing diseases in control programs. Examination at slaughter
has proved to be a poor indicator of lifetime pneumonia (Noyes
et al. 1990, Wallgren et al. 1990), and surveillance using clinical
herd inspection alone has failed to detect 30% of the infected
herds (Sørensen et al. 1993).
Bacterial culture has subsequently been introduced as a
diagnostic method into some disease-control programs. In
Denmark, the isolation of P. multocida from nasal swabs and
subsequent toxicicity testing is included in the disease-control
program (SPF) (Foged et al. 1988).  However, the efficacy of
bacterial cultivation is poor, and is not very applecable for A.
pleuropneumoniae and M. hyopneumoniae diagnosis. A.
pleuropneumoniae can only be isolated in the acute stage of the
disease (Nielsen 1988), and M. hyopneumoniae  often fails to
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grow on laboratory media. Isolation is readily obscured by
contaminating mycoplasma and bacteria (Armstrong 1994).
Furthermore, samples suitable for M. hyopneumoniae isolation
must be taken from a fresh lesion deep inside the lung lobes, a
procedure which requires narcosis of the pig.
Serology is a promising  diagnostic method for detecting
subclinical infections as well as clinical cases. The development
of the enzyme-linked immunosorbent assay, ELISA, which are
adaptable to simple serological test procedures and can be
extensively automated, contributed to the dramatic expansion of
diagnostic procedures during the 1980's and 1990's (Engval and
Perlmann, 1972). The assay is based on enzyme-labelled
immunoreactants, usually antibodies and more recently on
specific monoclonal antibodies. ELISA assays are available in a
variety of modifications, the basic sandwich method and the
competitive or blocking ELISA modifications being the most
widely used for the determination of antibodies. In general,
ELISA applications are considered to offer several advantages
over the earlier diagnostic methods, including faster availability of
the results, improved diagnostic sensitivity, and higher diagnostic
specificity (Scarman et al., 1997). Large numbers of samples are
easily obtained from living animals for serological testing, thus
increasing the reliability of the diagnosis (Martin et al. 1987). For
instance, the number of seropositive animals in the subclinical
form of M. hyopneumoniae infection in an infected herd can be
as low as 4%  (Levonen et al. 1992). If freedom from disease has
to be proven with 99% confidence on such a farm, the sample
size required is high, 27 samples when the number of breeding
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sows is 30 and the disease prevalence being below 5% (Martin et
al. 1987).
The use of colostrum samples for antibody determination in
pigs offers further diagnostic possibilities, because IgG is known
to concentrate in the colostrum (Stokes and Bourne 1989,
Wallgren et al. 1998). The IgG concentration is at its highest at the
moment of parturition,  and subsequently starts to decline. The
higher antibody concentration in colostrum lasts for 7-11 hours
(Sørensen et al. 1992, Nicolet 1988), after which colostrum turns
to milk, which contains less IgG than serum.
Antibodies, as measured by ELISA, have a long half life
(Bereiter et al. 1990). Once pigs have seroconverted, they most
often remain seropositive throughout their life. Therefore the
antibody concentration of sow’s colostrum reflects the long-term
infectious status of a herd. This is clearly of benefit when
confirmation of the freedom from disease is required. Other
regognised advantages areas follows: the collection of colostrum
samples causes very little stress to the sow, colostrum contains
more antibodies than serum, and colostrum samples can be taken
by the herd owner and frozen in a home freezer, pending assay.
This saves veterinary costs in sample taking.
Although the control of some respiratory diseases of swine in
a number of countries have included the use of serology, concern
has been expressed at  the specificity and sensitivity of the
serological methods used (Nicolet 1988, Nielsen 1988). For
example, M. hyopneumoniae and P. multocida toxin each evoke
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only a weak humoral antibody response, thus requiring a high
level of sensitivity from the serological test used, while A.
pleuropneumoniae possesses 12 partially cross-reacting
serotypes: thus heterogenity causes problems in the interpretation
of results (Nielsen 1988).
1.2 Enzootic pneumonia caused by Mycoplasma
hyopneumoniae
1.2.1 The agent, M. hyopneumoniae
The causative agent of enzootic pneumonia, M. hyopneumoniae
(Mare and Switzer 1965, Goodwin et al. 1965), belongs to the
mycoplasmas, which are the smallest prokaryotes known. They
do not have a cell wall, but  are bounded by a single trilaminar
membrane (Rosenbusch 1994). The most important swine
mycoplasmas are M. hyopneumoniae, which causes enzootic
pneumonia, M. hyosynoviae, which can cause arthritis, and the
mainly non-pathogenic  M. hyorrhinis and M. flocculare.
1.2.2 Enzootic pneumonia
Mycoplasma hyopneumoniae causes pneumonia characterised by
a chronic non-productive cough (Groendaelen 1972, Armstrong
1994, Kobisch and Friis 1996, Maes et al. 1996). The disease
causes retarded growth rate and inefficient feed utilisation, and
adversely effects the economic outcome of the affected swine
farms (Morris et al. 1995, Maes et al. 1999). In severe cases, and
in outbreaks in previously unaffected herds, abortions and
stillbirths can occur (Schulman 1988).  Pigs infected with M.
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hyopneumoniae are predisposed to secondary bacterial
infections, especially to A. pleuropneumoniae and P. multocida
(Ross 1992). M. hyopneumoniae and secondary infections result
in the so-called enzootic pneumonia complex, which is the most
common swine respiratory disease (Ross 1992) and which has a
more severe clinical picture than mycoplasmal pneumonia alone.
M. hyopneumoniae has been shown to potentiate porcine
reproductive  and respiratory syndrome virus (PRRSV) induced
disease and the occurence of lesions (Thacker et al. 2000). Pigs
free of M. hyopneumoniae have been shown to have a better
average daily weight gain and a lower mortality rate (Tuovinen et
al. 1994 b).
1.2.3 Epidemiology of M. hyopneumoniae
M. hyopneumoniae spreads readily by pig-to-pig contact.
Subclinical carrier swine play an important role in spreading  the
disease. Although airborne transmission has been proposed
(Christensen and Mousing 1992), in most cases the source of the
infection can be traced back to direct pig-to-pig contact. The
incubation period of M. hyopneumoniae infection is 10-16 days
(Ross 1992). In a herd, M. hyopneumoniae spreads slowly and
periods of 6 months-2 years have been reported between the
introduction of the infection in a herd and the overcome of clinical
signs (Goodwin 1984, Keller 1976). In endemically infected
herds, the piglets become infected after the protection provided
by maternal antibodies has disappeared. Seroconversion is at its
peak at the age of 4 months (Yagihashi et al. 1993). Most pigs
affected recover from mycoplasmal pneumonia and, in the
absence of secondary bacterial infections, the pneumonic lesions
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may disappear before the normal slaughter age of 6 months
(Noyes et al. 1990, Wallgren et al. 1990). Among feeder pigs
secondary infections are, however, common and the losses
incurred through respiratory diseases are considerable (Rautiainen
et al. 1991) and sows as a rule recover from M. hyopneumoniae
infections. Sows which have farrowed twice or more often rarely
transmit the agent (Waldman and Radtke 1937).
Spontaneous recovery on the entire pig herd is rare, if the
herd has more than 12 sows. Once infected with M.
hyopneumoniae, there are always pigs of susceptible age  which
continue to harbour the infection. The disease agent cannot be
eliminated by medication, and while vaccination only reduces
pneumonic lesions, it does not prevent the infection (Djordjevic et
al. 1997, Dohoo and Montgomery 1996, Zhang et al. 1994).
Possible methods of eradicating the pathogen include the
complete restocking or the adaption of a Waldman sanitation in
which only the sows that have had two or more litters are retained
(Waldman and Radtke 1937). One reason for the establishment of
the Finnish Pig Health Scheme was the need to produce a
replacement stock for the establishment of M. hyopneumoniae
free herds with high breeding value.
Morbidity in mycoplasmal pneumonia is very high. In the
major pig-producing countries most of the conventional pig herds
are affected (Armstrong 1994). In the United States, a study of
slaughter swine revealed that 99% of the herds had pigs with
pneumonic lesions, and a screening of antibodies in breeding
herds indicated that 60% of the herds were affected (Ross 1992).
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In Finland, the disease status with respect to enzootic pneumonia
is considerably better. The elite breeding herds are included in the
disease-control program and thus are free of enzootic pneumonia.
In south-western Finland only 10-15% of piglet-producing
multiplying herds are affected (Schulman 1988, Tuovinen et al.
1994a), and in western Finland, 30% (Rautiainen 1998).
1.2.4 Diagnosis of M. hyopneumoniae
Diagnosis of M. hyopneumoniae infection has been traditionally
based on the detection of clinical signs of pneumonia and the
examination of lesions post-mortem (Keller 1976, Goodwin
1977). Recording of clinical signs alone is not, however, an
especially accurate  diagnostic method because, as mentioned
earlier, surveillance through clinical herd inspection alone failed to
detect 30% of the infected herds (Sørensen et al. 1993).
Furthermore, periods of subclinical manifestation are common in
M. hyopneumoniae infections (Nicolet 1988). On the other hand,
environmental conditions such as dusty pig-house air can also
lead to mis-diagnosis of the disease.
Typical, but not pathognomomic macroscopical pathological
lesions of M. hyopneumoniae pneumonia consist of purple to
grey lobular areas at the apical and diaphragmatic lobes of the
lungs (Häni et al. 1976, Armstrong 1994). Histologically lesions
are characterised by peribronchial and perivascular aggregates of
lymphocytes (Häni  et al. 1976). On a herd basis, diagnosis is
routinely made at slaughter examination: however, the detection of
lung lesions at slaughter has proved to be a poor indicator of
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lifetime pneumonia (Noyes et al. 1990, Wallgren et al. 1990,
Morris et al. 1995).
More refined post-mortem diagnosing methods which hacve
been assessed include immunofluoresence and the isolation of M.
hyopneumoniae (Armstrong 1994).  Immunofluorecence has
provides a specific diagnostic method for M. hyopneumoniae:
however, this procedure often yields false negative results, thus
lacking sensitivity (Armstrong 1994). Regarding culture
techniques M. hyopneumoniae is a fastidious grower. Absolutely
fresh lung samples are required, and  isolation is often obscured
by other mycoplasmas especially M. hyorrhinis (Armstrong
1994, Ross 1992). Immunofluorescence and the cultivation of M.
hyopneumoniae are not readily adaptable  for use as diagnostic
methods within disease-control programs, due to the fact that
they are time consuming and too often yield false negative results.
Polymerase chain reaction (PCR) offers a rapid and precise
means for M. hyopneumoniae diagnostics (Stemke et al. 1994,
Harasawa et al. 1991,  Mattson et al. 1995, Artiushin and Minion
1996, Blanchard et al. 1996,  Stemke 1997). However, no PCR
application suitable for routine diagnostic use has so far  been
developed.
Serological methods for detecting M. hyopneumoniae
antibodies include indirect hemagglutination (IHA),
hemagglutination inhibition (HI), complement fixation (CF) test
and enzyme-linked immunosorbent assays (ELISA's) (Ross
1992). The ELISA is the most sensitive and specific serological
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test in M. hyopneumoniae diagnostics (Bereiter et al. 1990,
Bruggman and Keller 1977, Scarman et al. 1997).
1.3 Catarrhal pneumonia and pleuritis caused by
Actinobacillus pleuropneumoniae
1.3.1 A. pleuropneumoniae
A. pleuropneumoniae (formerly Haemophilus
pleuropneumoniae, Haemophilus parahaemolyticus) is a small,
gram-negative capsulated rod, with haemolytic activity on blood
agar media (Pfeiffer 1892, Shope 1964). A. pleuropneumoniae
has two biovars, of which biovar 1 is nicotine amide dinucleotide
(NAD) dependent   and biovar 2, which is NAD independent
altough it requires specific pyridine nucleotides or pyridine
nucleotide precursors for its NAD biosynthesis. At present, 12
main serotypes of A. pleuropneumoniae biovar 1 have been
identified (Nielsen 1988, Martin and Mulks 1999, Nielsen et al.
2000). Capsular polysaccharides and cellular lipopolysaccharides
are responsible for the serotype. Pathogenicity varies between
serotypes, and also between strains within one serotype
(Rosendal et al. 1985, Brandrecht and Smith 1987). The
serotypes 1, 5, 9, 10, and 11 are more virulent than the others
(Nielsen 1982, Komal and Mittal 1990). In Finland, serotype 2 has
been responsible for severe acute infections with high morbidity
and mortality if the swine affected are not treated (Prof. A.
Schulman, personal communication).
A. pleuropneumoniae secretes toxins  which have been
implicated as important virulence factors (Jansen et al. 1993,
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Kamp et al. 1994, Schaller et al. 1999). The nomenclature of these
toxins has been standardised as A. pleuropneumoniae-RTX-toxin
I (ApxI), A. pleuropneumponiae RTX-toxin II (ApxII), and A.
pleuropneumponiae-RTX-toxin III (ApxIII). Before
standardisation, several names were used for these toxins, such as
cytolysin, haemolysin and pleurotoxin. These toxins are not all
secreted by all serotypes: ApxI is secreted by serotypes 1, 5, 9,
10, and 11, ApxII by all serotypes except serotype 10, and
ApxIII by serotypes 2, 3, 4, 6, and 8.
1.3.2 Disease caused by A. pleuropneumoniae
Pathogenic A. pleuropneumoniae causes a severe necrotising
pneumonia and pleuritis in pigs. In acute infection, a  mortality
rate of up to 100% is possible (Nicolet 1992). A chronic but less
severe form of the disease is also known. This highly infectious
pathogen is encountered world-wide and it is a major cause of
morbidity and mortality in pigs (Olander 1963, Shope 1964,
Nicolet and König 1966, Nielsen 1970, Little 1971, Thörne and
Hakansson 1970, Schulman et al. 1975, Hsu et al. 1976, De Jong
1978). In effect,  A. pleuropneumoniae has spread to all
countries where intensive pig production is practiced (Nicolet
1992). The economic importance of the disease is principally due
to the high mortality rate and the veterinary costs incurred in acute
outbreaks. A. pleuropneumoniae infection may be complicated
by other respiratory infections such as mycoplasmal, viral and
other bacterial pneumonias, and is, therefore, a component of the
respiratory disease complex problem.
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The pathogenesis of pleuropneumonia assosiated with the
infection is not fully understood (Nicolet 1992, Oswald et al.
1999). In addition to Apx-toxins, capsular polysaccharide,
lipopolysaccharide and outer membrane proteins also act as
virulence factors for A. pleuropneumoniae (Komal and Mittal
1990). A. pleuropneumoniae primarily infects neutrophils and
alveolar macrophages (Min and Chae 1998). The pathogenicity is
multifactorial, involving the virulence factors of the bacterium and
endogenous host factors including induced immunity (Nicolet
1992).  However, pleuropneumonia can be caused by Apx toxins
alone (Kamp et al. 1997).
Passively transferred serum antibodies confer effective
protection against pleuropneumonia (Bossé et al. 1992). The
protection elicited by capsular polysaccharides is highly serotype
specific, whereas antibodies to the outer membrane proteins are
cross-protective (Thwaits and Kadis 1991, Martin and Mulks
1999).
 The acute form of pneumonia caused by A.
pleuropneumoniae is characterised by severe dyspnea, often with
blood-tinged froth in the nostrils, and death (Bertram 1985,
Nicolet 1992). The acute form of the disease resembles septic
shock in humans. In the peracute form the incubation period is
less than 24h, and an animal can die suddenly without preceding
signs. The chronic form is characterised by a cough of varying
intensity, and loss of appetite resulting in decreased weight gain.
In chronically infected herds there are often subclinically infected
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 1.3.3 Epidemiology of A. pleuropneumoniae
 Direct pig-to-pig contact is the most common route of spread of
A. pleuropneumoniae; however, it can also be spread by
infectious aerosols within a short distance, e.g. pen to pen, orone
room to another. Contaminated exudates from acutely affected
pigs can be spread to a new pig population by people,
transportation vehicles and other means (Nicolet 1992).
 
 The predominant serotype of A. pleuropneumoniae differs
between regions. Serotype 1 and 5 are the most widely spread in
Canada and the United States (Mittal et al. 1982, Rapp et al.
1985). In the Netherlands, serotype 9 causes the most severe
epidemics (Kamp et al. 1987). Serotype 2 is predominant in
Sweden, Denmark  and Schleswig-Holstein (Gunnarsson 1980,
Kielstein and Wuthke 1998, Møller et al. 1992, Nielsen 1982). In
Finland, only one the serotype, serptype 2, has been  isolated
from acute cases of pleuropneumonia to-date.
 
Once A. pleuropneumoniae  infection has become
established in a herd, it is difficult to eliminate the infectious agent,
although the herd appear to be healthy (Nicolet 1992). The
persistence of A. pleuropneumoniae in convalescent pigs
contributes significantly to the distribution of the disease (Hennig
et al. 1999).
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Commercially available vaccines reduce mortality but do not
prevent the development of the carrier state (Andresen 1997,
Chiers et al. 1998, Furesz et al. 1998). Cross-serovar protection
can be achieved through new  mutant  vaccine strains (Prideaux et
al. 1999).
Serological testing by CF followed by the removal of
seropositive pigs has been proposed as a means for eliminating A.
pleuropneumoniae infection from a herd (Nielsen 1982). This
method has also been used in Finland. However, while in the
short term the herd in question had appeared to be A.
pleuropneumoniae free, the infection later reappeared, indicating
that all the carrier animals had not been removed.
1.3.4 Diagnosis of A. pleuropneumoniae
In acute cases due to  A. pleuropneumoniae infection, the clinical
signs are characteristic and dramatic, whereas chronic
pleuropneumonia, and infections with nonvirulent strains may
appear in the subclinical form (Nicolet 1992). Typical pathological
changes are an aid for the diagnosis of A. pleuropneumoniae
related diseases. The predominant gross lesions are diffuse
fibrinous pleuritis, extensive amounts of blood-tinged froth in the
bronchial and tracheal lumina, pulmonary necrosis, haemorrhage,
infiltration of lymphocytes and macrophages, vascular thrombosis
and fibrin deposition in blood vessels and lymphatics (Bertram
1985). In the chronic form, there is focal chronic adhesive
pleuritis mainly in the caudal areas of the lungs and yellow to
grey-yellow necrotic masses (Häni et al. 1973). However, chronic
lesions caused by A. pleuropneumoniae cannot be distinguished
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on histopathological grounds from chronic pleuritis caused by
other bacteria, such as P. multocida (Nicolet 1992).
 Isolation of A. pleuropneumoniae requires NAD-enriched
media and incubation preferably in a 5% CO2 atmosphere
(Gunnarson 1979, Gunnarson 1990). The bacterium grows well
from samples obtained from acute lesions, but the specimens
obtained from chronic lesions are problematic and A.
pleuropneumoniae may be isolated occasionally from such
cases.
Detection of serotype specific antibodies is widely used in A.
pleuropneumoniae diagnosis (Nielsen 1982). The method most
commonly used has been CF. Certain cross reactions are
regularly detected by this method, namely 1-9-11, 3-6-8, and 4-7
(Nielsen 1988). The antibodies detectable by CF arise within two
weeks after the infection, and they persist for 3-4 months.
Antibodies detectable by various types of ELISA (Nicolet et al.
1981, Gunnarson 1980, Zimmermann et al. 1990, Nielsen et al.
1991, Bossé et al. 1990, Nielsen 1995, Stenbaek et al. 1997,
Leiner et al. 1999) last for longer period of time, and in practice,
for the lifetime of a sow.
 A  number of novel diagnostic methods have been recently
published. Most of them have to-date been used mainly in
research but, in the future, they can potentially be applied for the
laboratory diagnosis of A. pleuropneumoniae. A specific PCR
assay for the gene (omlA) coding for an outer membrane protein
of A. pleuropneumoniae serotypes 1 and 5 has been described
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(Gram and Ahrens 1998). Putative A. pleuropneumoniae isolates
can be verified by PCR (Moral et al. 1999). Various monoclonal
antibodies (mAbs) for distinct A. pleuropneumoniae strains have
been raised (Stenbaek et al. 1997, Lebrun et al. 1999, Bouh and
Mittal 1999). Restriction endonuclease analysis and plasmid
profiling could be useful in epidemiological studies of porcine
pleuropneumonia in the future (Wards et al. 1998).
 
1.4 Progressive atrophic rhinitis (PAR) caused by
toxigenic P. multocida
Progressive atrophic rhinitis is caused by toxigenic strains of
Pasteurella multocida. Bordetella bronchiseptica and non-
toxigenic strains of P. multocida are also involved in the atrophic
processes affecting the porcine conchae. A consensus has been
reached on the definition of the names of these atrophic disorders
(De Jong 1992). The name “atrophic rhinitis” includes all atrophic
processes of porcine conchae, and the term “progressive atrophic
rhinitis” (PAR) applies to a contagious disease caused by
toxigenic strains of P. multocida. This etiological definition of
PAR facilitates the identification of subclinically infected herds
that are cabable of transmit this severe clinical disease.
1.4.1 Toxigenic P.  multocida
P. multocida is a member of the genus Pasteurellaceae, which
consists of the genera Pasteurella, Actinobacillus, and
Haemophilus, along with several other groups of animal parasites
and pathogens (Mutters et al. 1989). P. multocida is an important
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animal pathogen which is distributed throughout the world
(Rimler and Rhoades 1989). The bacterium can also infect
humans (Avril et al. 1990, Nielsen and Frederiksen 1990). Toxin-
producing strains of P. multocida were first shown to cause non-
reversible conchal atrophy by I'lina and Zasukhin (1975) and De
Jong et al. (1980). Toxigenic strains of P. multocida can be
found within the serotypes D and A (P. multocida has five
capsule serotypes A,B,D,E, and F).
P. multocida does not  colonise the intact respiratory
epithelium. The epithelium is first damaged by another infectious
agent or by exposure to high ammonium concentrations in the
pig-house air (Hamilton et al. 1996). The most common primary
invader in PAR is  Bordetella bronchiseptica (De Jong 1992,
Sakano et al. 1997). Apx-toxins of A. pleuropneumoniae render
the infected animal more susceptible to secondary infections such
as P. multocida through impaired function of porcine alveolar
macrophages (PAM) (Cruijsen et al. 1992, Chung et al. 1993).
Also M. hyopneumoniae infection can render the lungs
susceptible to P. multocida colonisation (Amass et al. 1994). In
challenge models, Pasteurella multocida toxin (PMT) has been
demonstrated to be cabable of causing progressive atrophic
rhinitis alone (Foged 1988, Van Dieman et al. 1994).
 PMT is a proteinous toxin the production of  which is an
essential component for the formation of irreversible conchal
atrophy. The estimates of its molecular weight range from 112 to
160 kDa (Rimler and Rhoades 1989) and  143kDa (Foged et al.
1988). The toxin produces haemorrhage and is dermonecrotic in
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guinea pig skin. The toxin is lethal for mice, rats, guinea pigs,
swine and turkeys. Toxin-producing P. multocida strains have
been found in swine, cattle, goats, rabbits, cats, dogs, turkeys,
and man (Nielsen and Fredriksen 1990). Naturally occurring
progressive atrophic rhinitis has also been described in goats
(Rimler and Rhoades 1989, De Jong 1992). Undefined
Pasteurella strains which produce a similar toxin have  caused
atrophic rhinitis in cattle (Kamp et al. 1990).
1.4.2 Progressive atrophic rhinitis (PAR)
Progressive atrophic rhinitis is a respiratory disease of pigs
characterised by chronic progressive atrophy of the nasal
conchae, sneezing and, in severe cases twisting or shortening of
the snout, and nasal haemorrhage (De Jong 1992). The form of
the disease varies from a subclinical manifestation of the disease
to a severe form associated with considerable growth retardation.
The clinical signs of progressive atrophic rhinitis are
associated with the toxic effects of PMT. PMT induces a rapid
increase in the number of chondroclasts and osteoclasts
(Martineau-Doizé et al. 1991, Gwaltney  et al. 1997), and thus
affects bone formation in the nasal conchae, causing even
complete atrophy of conchae in some cases. Parenteral injections
with PMT induced liver cirrhosis, renal failure, marked decrease
of peripheral blood lymphocytes without lysis, and growth
retardation (De Jong 1992). Systemic changes induced by PMT
are weight loss, hepatic necrosis, leucosytosis, elevated
complement titre and, in high doses, death (Pettit et al. 1993). The
clinical signs seen in pigs kept under farming conditions include
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sneezing, lachrymal secretion, nasal bleeding, distortion of the
snout, poor growth resulting in overall poor appearance and
uneven growth pattern of the pigs.
1.4.3 Epidemiology of toxigenic P. multocida
The most important route by which PAR is introduced  into a
previously uninfected herd is by carrier animals (De Jong 1992).
However, infectious aerosols and fomites also play a role in the
transmission of atrophic rhinitis (Thomson et al. 1992).
The clinical picture of progressive atrophic rhinitis differs
depending on the housing conditions and management factors on
the farm (De Jong 1992). High ammonia content in pig house air
enhances colonization by  toxigenic P. multocida on the nasal
turbinates (Foged et al. 1989, Andreasen et al. 2000).  Also
previous respiratory infections such as enzootic pneumonia rends
pigs more susceptible for progressive atrophic rhinitis (Ross
1992).
In an infected herd, the prevalence both of clinically diseased
animals and non-clinical carriers of the toxigenic  P. multocida
bacterium varies over the course of time. Subclinical periods
ranging from 3 months to 2 years are commonly reported
between the periods when the disease is evident.
Vaccines against atrophic rhinitis are available. These are
effective in preventing and alleviating the clinical disease, but they
do not prevent infection by toxigenic  P. multocida.
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1.4.4 Diagnosis of PAR
Traditionally diagnosis of atrophic rhinitis has been determined by
estimating the degree of conchal atrophy post-mortem
(Martineau-Doizé 1991).  This method can be used to estimate the
severity of atrophic rhinitis in a herd, but the presence of
toxigenic P. multocida and thus progressive atrophic rhinitis
cannot be determined by this means alone.
Isolation of P. multocida from progressive atrophic rhinitis
cases in swine is best achieved by culturing nasal swabs or tonsil
swabs or biopsies. Because other nasal flora may mask the
presence of P. multocida, selective media should be used
(Pedersen 1983). The toxicity of the isolate can be measured by
the mice lethality test, guinea pig skin test, ELISA, by testing
cytopathogenicity on embryonic bovine lung or vero cells, and by
detecting the toxin production gene by means of DNA probes
(De Jong et al. 1980, Pedersen 1983, Foged et al. 1988, Pennings
and Storm 1984,  Kamps et al. 1990, Rutter and Luther 1984). Of
these methods, the ELISA  has been found to be the best method
for the determination of toxicity (Foged et al. 1988, De Jong
1992).
Due to a lack of sensitive tests, serology has not been used
for the control of PAR in pig herds. However, an ELISA has
been used for PMT antibody measurement in vaccine trials
(Foged et al. 1989, Foged et al. 1990). A serum neutralisation test
on embryonic bovine lung (EBL) cells has also been described
(Bechmann and Schöss 1990, Alt et al. 1992).
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When choosing a diagnostic method for detecting  PAR in
pig herds, especially in the case of disease control programs, the
fact that interruptions between periods of clinical disease are
typical for chronic PAR in a herd, should be taken into account.
These subclinical phases can vary from 2 months to about two
years (De Jong 1992). Herd monitoring based on clinical and
pathological features alone cannot guarantee the absence of
infectious PAR in a pig herd. Complementary monitoring of a
herd, based on bacteriological  and/or serological detection of the
PAR-toxigenic  P. multocida, has been regarded as being
necessary in orserto obtain sufficient information about the PAR-
infected or PAR-free status of the herd (De Jong 1992, Matscullat
et al. 1994).
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2. Aims of the study
1. To employ commercial antibody test kits for M.
hyopneumoniae and to evaluate their usefulness in surveying the
disease status in breeding herds using sow colostrum as a sample.
2. To create an enzyme-linked immunosorbent assay (ELISA) for
the detection of A. pleuropneumoniae antibodies.
3. To modify a P. multocida toxin ELISA  to detect P.
multocida toxin antibodies and to assay the toxin antibodies in
sow’s colostrum.
4. To determine the prevalence of antibodies to M.
hyopneumoniae, A. pleuropneumoniae and P. multocida toxin in
breeding sows.
5. To determine the prevalence of different serotypes of A.
pleuropneumoniae in different areas of the country in order to be
able to effectively target the national disease-control program.
6. To evaluate the usefulness of antibody assays in the disease-
control program for swine breeding farms.
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3. Materials and methods
3.1 Collection of colostrum and serum samples
For the M. hyopneumoniae (I), A. pleuropneumoniae (III) and
P. multocida (V) toxin antibody surveys, the herd owners of the
193 farms participating in the Finnish Pig Health Scheme were
requested to take colostrum samples from all their sows that  far-
rowed during a period of six months. Sampling  the same farm
twice a year facilitated the follow-up of the disease situation.
Between November 1989 and April 1991 a total of 6,256
colostrum samples were received. Eight farms did not participate
in the survey.
In order to obtain reliable results from antibody assays of
colostrum, the samples  were required to be taken during
farrowing or immediately afterwards. In order to control the right
sampling time, the farrowing time (delivery of the first piglet) and
the sampling time were recorded. The samples were kept frozen
on the farms and sent to the laboratory in batches of 10 to 20.
M.hyopneumoniae samples
The final number of herds tested for M. hyopneumoniae
antibodies  (I) was 185. All the 5,830 samples received were
tested for M.hyopneumoniae antibodies. When positive or
suspicious colostra were recorded, the farmers were asked to
send extra follow-up samples. A total of 426 such samples were
received from 20 herds.
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For testing the repeatability of Chekit®Hyoptest for detecting
M. hyopneumoniae antibodies  (II), 60 colostrum samples were
selected from the above mentioned samples and 20 serum
samples were also examined. Samples from both infected and
noninfected herds were included.
The diagnostic performances of two different commercial  M.
hyopneumoniae ELISA test kits  (II) were compared, using
samples from 7 selected herds.  The farms were chosen so that
on 3 of the farms the pigs had clear signs of enzootic pneumonia,
and  on 4 farms the animals were non-clinical and in the latter
case, only a single positive reactor was found in preliminary
assays.
In this study a total of 153 colostrum samples were assayed
with both Chekit® Hyoptest and DAKO M. hyopneumoniae
ELISA.
A. pleuropneumoniae samples
The amount of colostrum in some samples was sufficient only for
the M. hyopneumoniae survey. This resulted in fewer sows and
herds being tested for A. pleuropneumoniae serotype 2
antibodies (III):  5,477 colostrum samples from 182 herds were
tested.  All the sows in 154 herds were tested, and 17% to 68%
of the sows in 28 herds.
In addition to colostra, serum samples for the A.
pleuropneumoniae 12 serotypes survey (IV) were randomly
collected from sows in Finnish slaughterhouses.  At the time of
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this survey there were seven abattoirs slaughtering swine in
Finland. The number of samples taken in each slaughterhouse was
proportional to the sow population in the collection area. A total
of 736 blood samples were collected. In some of the samples
there was too little serum to test all the 12 serotypes, and
therefore the number of samples assayed for the different
serotypes varied as folows: 736 for serotypes 1 and 2, 718 for
serotype 3, 690 for serotypes 4-6, and 675 for serotypes 7-12.
P. multocida samples
For P. multocida toxin antibodies (V)  5,650 colostrum samples
from 188 herds were tested. Six further herds with applications
pending for inclusion in the Scheme were allowed to participate in
the PMT antibody survey. All the sows were tested in 166 herds,
but 22 farmers sampled only some of their sows. Producers who
had sent spoiled samples (31 batches, 453 samples) were asked
to collect new colostra from successive farrowings
In order to reveal the origin of the PAR infection on farm no.
20, serum samples, which were collected from  58 imported pigs
during the quarantine period,  were included in the survey and
screened for  P. multocida toxin antibodies (V).
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3.2 Bacterial strains used for the production of  A.
pleuropneumoniae antigen and for immunisation
of rabbits
The following A. pleuropneumoniae strains were used for ELISA
antigen preparation and for immunising rabbits to obtain antisera
for testing cross reactions: serotype 1: 4074, serotype 2: ATCC
27089, serotype 3: ATCC 27090, serotype 4: M 62, serotype
5a:K 17, serotype 5b: L 20, serotype 6: Femø, serotype 7: MF 83,
serotype 8: 405, serotype 9: CVJ 13261, serotype 10: 3039,
serotype 11: 56153, and serotype 12: 8329. The ATCC type
strains were obtained from the American Type Culture Collection,
and the other strains were generous gifts from Statens Veterinære
Serumlaboratorium, Copenhagen, Denmark.
3.3 Control serums in A. pleuropneumoniae
ELISA
The positive control serum used in A. pleuropneumoniae
serotype 2 ELISA (III) was a field serum obtained from a herd of
a progeny testing station previously free of A. pleuropneumoniae,
but which had subsequently been acutely infected with A.
pleuropneumoniae serotype 2. The serum  was collected two
months after the acute outbreak of the disease. The serum was
tested with a complement fixation test (CF) (Nielsen 1982) and
gave a titre of 1:64. Using a competitive ELISA (Nielsen et al.
1991) the titre was 1:32. Checkerboard titration was performed on
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the sera and the antigen. A dilution of 1:1000 of the serum was
chosen as the best working dilution for an antigen diluted to 1:50.
The negative control serum (III, IV) was a serum from a
disease-control herd with a long known A. pleuropneumoniae –
free history and presently having no clinical signs of pneumonia.
The pigs that were bled had no pneumonic lesions in
slaughterhouse examination. The serum was found to be negative
for A. pleuropneumoniae antibodies with the CF assay and the
competitive ELISA.
Rabbit antisera against each serotype was used for ELISA’s
for the other serotypes  (IV). In serotype 3 and 4 assays swine
antisera against these serotypes were used.  These sera were
generous gifts from SVA, Sweden. Checkerboard titrations were
performed to determine the suitable dilution for the control
serums. The positive control serum was used in a dilution which
gave an OD value of 0.5 after 10 min reaction.
3.4 Performing the M. hyopneumoniae ELISA
Colostral and antibodies against M. hyopneumoniae (I,II) were
determined according to the manufacturer's instructions using a
commercial ELISA kit, Checkit®Hyoptest,  Dr. Bommeli AG,
Bern, Switzerland. Diluted porcine or colostra (1:100) were added
to the microtiter wells previously coated with Tween 20
solubilized crude M. hyopneumoniae antigen (Bommeli 1986,
Nicolet et al.  1980). After 1.5 h incubation at room temperature
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the plate was washed with PBS-Tween 20, and a rabbit anti-swine
horseradish peroxidase (HRP) conjugate was added. After 1.5 h
incubation at room temperature the plate was washed and then
incubated with a chromogen solution (ABTS; 2,2'-azino-bis [3-
ethylbenzthiazoline-6-sulfonic acid] diammonium). The colour
reaction was stopped with 0.5% SDS (sodium dodecyl sulphate).
The photometric results were obtained at a wavelength of 409 nm
using  a photometer (Multiscan MCC, Labsystems, Helsinki,
Finland). Samples which gave an optical densitity (OD) 95% or
over of the positive control serum (weak positive) were regarded
as positive, and samples which gave an OD 70-95% of the
positive control were regarded as suspicious.
To determine any cross-reactions between M. hyorrhinis
(I), which is commonly found in pigs in Finland (Schulman et al.
1970), and M. hyopneumoniae, rabbit hyperimmune sera were
tested in serial dilution from 1:100 to 1: 3200 against M.
hyopneumoniae antigen using the ELISA assay. The rabbit
hyperimmune sera against M. hyopneumoniae and against M.
hyorrhinis were donated by Dr. Freund, Arhus, Denmark.
The Dako M. hyopneumoniae antibody ELISA (II) (DAKO
A/S, Denmark) is a competitive ELISA in which a specific
monoclonal antibody (mAb) competes with any comparable
antibody in the samples (Feldt et al. 1992). The kit was a
prototype, which had been sent to our Laboratory for evaluation
of its performance. The samples were diluted 1:10 and incubated
in microwells precoated with M. hyopneumoniae antigen for 1.5 h
at room temperature. A specific peroxidase conjugated
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monoclonal antibody to M. hyopneumoniae was added to the
wells to compete with the samples. The conjugate and the
samples were incubated together for 15 min, and thereafter the
wells were washed. A chromogenic substrate (OPD) was added,
the colour was allowed to develop for 10 min in the dark, and the
colour reaction was stopped by adding sulphuric acid. The
optical densities were read by means of a photometer (Multiscan
MCC, Labsystems, Helsinki, Finland) at a wavelength of 492 nm.
The results were interpreted as percentage of the buffer control
wells (Buffer + conjugate + chromogen), and samples which had
an OD of less than 50% of the buffer control were regarded as
positive.
3.5 Immunisation of rabbits to obtain A.
pleuropneumoniae antisera (III,  IV)
Antibodies against 12 A. pleuropneumoniae serotypes were
raised in rabbits. The immunisation process was  performed as
follows: 6 h cultures of A. pleuropneumoniae on PPLO agar
(Difco, Detroit, MI, USA) were harvested in 1% formol saline,
kept overnight, diluted with saline to the density of Mc Farland
tube no.4, mixed with Freunds incomplete adjuvant (Difco
Laboratories, Detroit, Michigan, USA) and injected
intramuscularly into two sites (1ml + 1ml). Two rabbits were
injected with each serotype. The booster injections (0.5 ml) were
given intravenously twice a week for three weeks. The bacterial
suspension for the first booster injection was of low density; Mc
Farland tube no.1, thereafter the injections were of the density of
Mc. Farland no.4. The first three booster injections were
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suspended in 0.2% formol, and the last three were without
formol. The rabbits were bled one week after the last i.v.
injection, and the sera were stored at -70°C until use.
3.6 Preparation of A. pleuropneumoniae antigen
The antigen for the A. pleuropneumoniae ELISA (III,IV) was
prepared according to Gunnarson (1979), with some modifica-
tions. Each of the  above-mentioned A. pleuropneumoniae strains
was grown on (pleuropneumonia like organisms) PPLO agar for 6
h. The bacterial growth was suspended in phosphate buffered
saline (PBS, pH 7.4). The suspension was centrifuged at 4000xG
for 20 min at 4°C. The sediment was weighed and suspended in
distilled water to 20 times the weight of the sediment. An equal
volume of 90% phenol was added and the mixture was heated
under magnetic stirring for 20 min at 62°C. The mixture was then
centrifuged (4000xG) for 20 min at 4°C. The supernatant was
collected, the pellet was resuspended with 20 times its weight of
water, heated under magnetic stirring, centrifuged (4000xG) and
the supernatant was collected. The supernatants were dialysed
against distilled water overnight at 4°C and used as an antigen in
the A. pleuropneumoniae ELISA at a dilution of 1:50.
3.7 Coating of microwell plates with A.
pleuropneumoniae antigen
For coating the microwell plates for A. pleuropneumoniae ELISA
(III,IV) the antigen was diluted 1:50 with 0.05M sodium bicarbon-
ate buffer, pH 9.5-9.6. 100 µl aliquots of the diluted antigen were
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pipetted into 96 well microtiter plates (Nunc Immunoplate
Maxisorb, Roskilde, Denmark). The plates were incubated in a
humid chamber for 6h in room temperature and then washed with
three times PBS+ 0.5% Tween 20. Gelatine solution (1%,
blocking reagent) in PBS-Tween was added to the wells, which
were then incubated overnight in room temperature in a humid
chamber. Thereafter, the plates were washed three times with
PBS-Tween and stored wrapped in plastic at 4°C until used.
3.8 A. pleuropneumoniae ELISA assay (III)
Colostrum samples were thawed and centrifuged for 6 min at
13,000 rpm (Microliter, Hettig Zentrifugen, Tuttlingen,
Switzerland) and the cream fraction was discarded. The
colostrum samples and the positive and negative control sera
were diluted 1:1000 with PBS + 0.05% Tween20 + 10% fetal
bovine serum (FBS). 100µl aliquots of diluted samples were
pipetted into the coated microtiter wells and the plates were
incubated for two hours in a humid chamber at room temperature,
and thereafter washed three times with PBS-Tween. Peroxidase-
conjugated rabbit anti-swine-Ig, heavy and light chain specific
(Cappel, Organon Teknika Corporation, Cochranville, PA, USA)
was diluted 1:4000 with PBS + 0.05% Tween20 + 10% FBS and
added to the wells (100 µl). The plates were again incubated for 2
h in a humid chamber at room temperature and washed three
times with PBS-Tween. A 2,2'-azino-bis diammonium tablet (10
mg) was dissolved in 45 ml of substrate buffer (0.1M citric acid +
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0.1M Na2HPO4 added to a pH of 4.0) and 9ml of 33% H2O2 was
added. 100 µl of substrate was pipetted into the wells and the
colour reaction was allowed to develop for 5-10 min. 50 µl of
sodium dodecyl sulphate (SDS) was added to stop the colour
reaction. The optical densities (OD) were measured using a
photometer (Multiscan MCC, Labsystems) at a wavelength of 560
nm. The samples which gave an OD equal to or above that of the
positive control were regarded as positive.
3.9 The ELISA assay for 12 A. pleuropneumoniae
serotypes (IV)
The ELISA assay used for the detection of 12 serotypes was a
modification of that used for the serotype 2 assay. The  samples
and the negative control serum were diluted 1:1000 with PBS +
0.05% Tween 20 + 10% fetal bovine serum (FBS). Diluted
samples (100 µl) were pipetted into the coated microtiter wells.
The plates were incubated for 2 h in a humid chamber at room
temperature and thereafter washed three times with PBS-Tween.
Peroxidase conjugated rabbit anti-swine-Ig, heavy and light chain
specific (Cappel, Organon Teknika Corporation), was diluted
1:4000 with PBS + 0.05% Tween20 + 10% FBS and added to the
wells (100 µl). Peroxidase conjugated goat anti-rabbit-Ig (Dako
A/S, Glostrup, Denmark) was diluted 1:750 and added to the
positive control and buffer control wells. The plates were again
incubated for two hours in a humid chamber at room temperature,
and washed three times with PBS-Tween. A 2,2'-azino-bis
diammonium tablet (10 mg) was diluted in 45ml of substrate
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buffer (0.1M citric acid + 0.1M Na2HPO4 added to pH 4.0) and
9microl of 33% H2O2 was added.  Substrate (100 µl) was
pipetted into the wells and the colour reaction was allowed to
develop until the OD of the positive control serum was
approximately 0.5. The OD of the negative control serum should
not  exceed 0.2. The reaction was stopped by adding 50 microl
of 0.5% sodium dodecyl sulphate (SDS). The optical densities
(OD) were measured using a photometer (Multiscan MCC,
Labsystems, Helsinki, Finland) at a wavelength of 560 nm.
Samples giving an OD of 0.5 or more were regarded as positive.
3.10 Testing cross reactions in A.
pleuropneumoniae ELISA (III, IV)
Rabbits were immunised against strains of serotypes 1, 2, 3, 4,
5a, 5b, 6, 7, 8, 9, 10, 11, and 12. Reactions with each serotype
antigen were tested at 10 serum dilutions between 1:100 and
1:6000. Serotype 2 rabbit antiserum was further diluted to 1:8000,
1:12,000, 1:16,000, 1:20,000, and 1:24,000. The ELISA test was
performed as described above, using peroxidase-conjugated goat
anti-rabbit Ig-G as a conjugate.
3.11 Repeatability of the test in A.
pleuropneumoniae ELISA (III)
To test the repeatability of the A. pleuropneumoniae serotype 2
ELISA, 44 colostrum samples were assayed twice using microti-
ter plates which had been coated on separate occasions.
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Agreement between the assays was assessed according to Martin
et al. (1987).
3.12 ELISA for detection of P. multocida toxin
(PMT) antibodies (V)
The serological blocking ELISA was developed using the anti-
PMT kit of Dako (Dako A/S, Glostrup, Denmark). Both
monoclonal and polyclonal antibodies, which recognise different
antigenic epitopes of PMT, were used in the ELISA. The wells of
the ELISA plate were coated with the monoclonal antibody, while
the polyclonal antibody was conjugated with horseradish
peroxidase (HRPO). PMT was trapped on the solid phase by the
MAb. The antibodies in the samples inhibited the binding of RPO
conjugate to the PMT antigen. The amount of bound conjugate
was measured spectrophotometrically after the addition of
chromogen. The monoclonal antibody and the conjugated
polyclonal antigen were included in the commercial test kit.
The next step was developed from the PMT ELISA in order
to detect the anti-PMT-antibodies. The PMT and colostrum
samples were first preincubated in a dummy plate. Equal amounts
of PMT (0.2mg/ml) and colostrum, 40 ml of each, were placed in
the wells (Foged 1988).  Colostra were used in 1:2 dilution
(dilution buffer PBS + 0.5% Tween 20 + 1% BSA);  the sera
were undiluted. The positive control used was antiserum,




4.1 The M. hyopneumoniae ELISA test
In the M. hyopneumoniae survey (I) 6,256 colostrum samples
were tested for M. hyopneumoniae  antibodies, and  61  positive
or suspicious samples were found (Table 1). 33 of these samples
came from herds in which no clinical signs of M. hyopneumoniae
infection, no pathological findings indicative of M.
hyopneumoniae infection and no further positive reactions in
follow up samples were found. The herds were observed for two
years after the first positive samples. Some samples were later
found to be negative in confirmatory assays (II). The 33 herds
which were found to have singleton reactors were considered to
be non-infected, and the samples were regarded as false-positive
samples.
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Table 1. The results of serological, clinical and pathological




Sows Samples Positive Suspected Signs Pathology  Follow-up
Group A. Diagnosis confirmed
16 30 36 4 3 + EP   1/20
39 17 21 0 3 + EP            -
62 20 18 1 0 + EP   2/23
102 17 15 1 0 + EP   1/25
141 20 16 3 1 + EP   6/11
178 30 13 0 5 + EP   2/19
Group B. Diagnosis not confirmed
8 56 47 1 2 - -  0/11
12 50 27 1 0 - -  0/19
13 40 36 2 0 - -  0/11
17 40 21 1 2 - -   1/34
40 32 34 1 4 - -   1/19
61 21 11 1 0 - -  0/13
65 6 6 1 0 - -  0/5
79 21 18 1 0 - -  0/12
85 35 31 1 0 - -  0/26
86 36 21 1 0 - -  0/52
99 30 31 1 0 - -  0/16
101 32 40 1 0 - -  0/16
132 40 36 1 0 - -   1/40
167 25 19 8 2 - -   2/9
183 55 33 1 0 - -  0/17
Group C. Follow-up still going on
120 25 1 1 ND ND ND
153 36 1 0 ND ND ND
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The OD values of positively reacting colostra in the
positive herds varied between 0.243 and 2.000 (mean 0.678; SD ±
0.376). The mean OD value for the negative control serum was
0.064 (SD 0.052) and for negative colostra, 0.067 (SD 0.049).
The specificity of the test was 99.4%. This refers to the
proportion of negative and suspicious colostra from the herds,
which did not develop clinical or pathological enzootic pneumo-
nia during the study period. Herd specificity based on herds
without clinical enzootic pneumonia that tested negative, was
91,5%. The apparent sensitivity of the assay was 66.7%. The
samples from two diseased herds gave ELISA ODs that were
regarded as suspicious. The OD values were, however, near to
the cut-off level of the positive control. If the suspicious
reactions were to be  categorised as positives, then  the assay has
a 100% sensitivity at the herd level.
4.2 Cross-reactions with M. hyorrhinis
When specific, hyperimmune antisera against M. hyopneumoniae
and M. hyorrhinis were assayed using M. hyopneumoniae anti-
gen, both reacted positively (I). With M. hyopneumoniae anti-
serum the strong reaction (OD 1.700) started to decline at
dilutions between 1:2000 and 1:3200 (OD 1.102). The top level of
M. hyorrhinis antiserum was much weaker, OD 0.972, and the
1:1600 dilution (OD 0.312) was the last dilution that gave positive
result.
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4. 3 Repeatability of the Chekit®Hyoptest
When testing samples in two occasions with the Chekit®Hyoptest
M. hyopneumoniae ELISA (II), samples  found to be positive or
suspicious in the first test tended to change to suspicious or
negative respectively in the second assay. The negative samples
remained negative. The observed proportion agreement was 75%
(Martin et al. 1987). If suspicious samples were regarded as
positive, then kappa was 0.65, and if  suspicious samples were
regarded as negative, kappa was 0.71, indicating good agreement.
4. 4 Comparison of the Chekit®Hyoptest and
DAKO M. hyopneumoniae ELISA
The DAKO M. hyopneumoniae ELISA identified more positive
animals (70/153) than the Chekit®Hyoptest (30/153) (II). Ten
samples that were suspicious according to the Hyoptest were
positive with the DAKO test. Due to the fact that both assays
were used as herd tests, only herd sensitivity could be estimated.
Both ELISAs were able to identify as positive the three M.
hyopneumoniae diseased herds. The herds tested had been
selected from known infected and noninfected herds (Table 1).
Both ELISAs detected each of the three truly infected herds,
indicating that the sensitivity is high enough for eradication
requirements. The results of the study (II) suggested that the
single reactors in noninfected herds were false positives. Based
on these results the apparent specificity of the DAKO test was
99.3% and the apparent specificity of the Hyoptest was 98.0%.
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4.5 Control sera in the A. pleuropneumoniae
ELISA
The positive control serum for serotype 2 gave an average OD of
0.535 (SD ±0.126) for 143 determinations (III). In the 12
serotypes survey (IV) the mean OD value of the positive control
serum was 0.640 (SD ±0.04), and varied between serotypes from
0.53 for serotype 5 to 0.7 for serotype 11.
The mean OD for the negative control serum was 0.1006
(SD ±0.048) in the serotype 2 assay (III) and 0.130 (SD ±0.080)
in the 12 serotypes survey (IV).
The cut-off point of the ELISA for the 12 A.
pleuropneumoniae serotypes (IV) was set at 0.5. This was
chosen decided after testing different positive sera, serial dilutions
of  positive sera and sera from negative herds. In order to
minimise the variability between assays, only positive control sera
with an OD figure of 0.5 or higher were included. Because the OD
values were assassed visually before stopping the reaction, the
values varied only slightly from test to test.
4.6 Repeatability of the A. pleuropneumoniae
ELISA
Of the 44 samples assayed twice in the  A. pleuropneumoniae
serotype 2 ELISA, 15 were cocsistently positive and 21 negative
in both assays. In the agreement testing (Martin et al. 1987) kappa
was 0.63, indicating good agreement.
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4.7 Cross-reactions in A. pleuropneumoniae
ELISA
The OD values of each serotype rabbit antiserum at a dilution of
1:1000 with each serotype antigen are presented in table 2. All
these rabbit antisera reacted with the homologous antigen. In
addition, serotypes 1, 9 and 11 cross-reacted. Serotypes 6 and 8
also cross-reacted, and serotype 5(a) antiserum reacted with
serotype 6 antigen. Slightly different cross reactions were found
when the field samples were studied: the OD values of the
samples reacting with serotypes 9 and 11, 9 and 12, and 1 and 2
showed some correlation (p<0.01).
Table 2. Reactions of A. pleuropneumoniae serotype 1-12 sera
against serotype 1-12 antigen.  OD values with serum dilution
1:1000.
antig. 1 2 3 4 5a 6 7 8 9 10 11 12
antis.1 0,65 0,04 0,04 0,09 0,02 0,08 0,06 0,15 0,78 0,03 0,62 0,02
antis.2 0,06 0,49 0,04 0,06 0,01 0,09 0,06 0,21 0,03 0,04 0,06 0,02
antis.3 0,02 0,08 0,56 0,01 0,02 0,16 0,03 0,20 0,02 0,07 0,04 0,02
antis.4 0,06 0,15 0,08 0,90 0,05 0,08 0,10 0,09 0,04 0,06 0,07 0,04
antis.5a 0,03 0,08 0,06 0,06 0,60 0,66 0,07 0,09 0,03 0,02 0,03 0,04
antis.6 0,01 0,04 0,02 0,01 0,01 0,59 0,04 0,67 0,06 0,02 0,03 0,02
antis.7 0,03 0,02 0,03 0,01 0,03 0,01 0,64 0,03 0,04 0,02 0,02 0,02
antis.8 0,04 0,05 0,24 0,03 0,20 0,36 0,03 0,75 0,06 0,04 0,03 0,03
antis.9 0,50 0,03 0,02 0,02 0,01 0,03 0,05 0,01 0,70 0,01 0,69 0,02
antis.10 0,09 0,10 0,03 0,03 0,01 0,19 0,06 0,07 0,04 0,68 0,03 0,03
antis.11 0,75 0,07 0,05 0,03 0,02 0,02 0,04 0,01 0,77 0,04 0,87 0,04
antis.12 0,02 0,08 0,05 0,04 0,18 0,03 0,06 0,02 0,01 0,02 0,00 0,90
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The cross-reactions were evident only at the initial, low serum
dilutions. At higher dilutions the reactions were specific. The A.
pleuropneumoniae serotype 2 antiserum reacted very strongly
with serotype 2 antigen to a dilution of 1:6000. Thereafter the
ODs began to decline, but even at the dilution of 1:24,000 the OD
was still 0.371.
4.8 Positive samples in the anti-PMT ELISA
The mean titre of the positive colostrum samples was 61.0, with a
SD of ±141.1, minimum 1.11, and maximum 473.8. Compared to
the positive control serum, the mean ratio of the titre sample: titre
positive control (Ts:Tp) was 1.66, with a SD of  ±3.36. Single
positive samples were found in 11 herds. Based on repeated
laboratory tests combined with clinical and pathological
evaluations, these findings were categorised as false positives.
The average titre of the false positives was 1.740 (SD ±0.230) and
the average Ts:Tp  ratio 0.051 (SD ±0.052).
4.9 Specificity and sensitivity of the anti-PMT
ELISA
As only 11 false positive samples were recorded, a specificity of
99.8% was determinated. Owing to the low number of positive
samples and the lack of a reference method, only a crude estimate
of the specificity of the test could be made, however.
50
In the infected herd, 11 of the 21 sows had measurable
amounts of antibodies to PMT in their colostrum. The apparent
sensitivity at the individual level in this case was therefore at least
52%, and at the herd level, 100%. The recovery rate of toxigenic
P. multocida from nasal swabs was 55%.
Spoiled samples of colostrum having a foul odour were
found in 31 batches (453 samples). These samples gave a positive
reaction in the anti-PMT ELISA. The farms of origin were
requested to send a fresh batch of samples, and when these
samples of good quality were assayed, they gave negative results.
4.10 M. hyopneumoniae survey
In the M. hyopneumoniae survey 6,256 colostrum samples from
185 breeding swine herds were tested for M. hyopneumoniae
antibodies. Altogether 61 positive, or suspect, samples were
found in 23 herds: six of these herds had been certified as M.
hyopneumoniae infected. All the herds participating in this survey
were followed closely for two years after the first collection of
colostra.
The percentage of positive samples in the six infected  herds
averaged 10.3%. If the suspect samples were to be  clarified  as
positive, then  the mean percentage of positives would be 18.2%.
The percentage of combined positive and suspect reacting sows
in these herds varied between 5.6% and 38.5%.
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The antibody increase was detected earlier than were the
clinical signs: In four of the truly infected herds the first positive
colostrum was found from 4 days to 6 months before the
detection of the first clinical signs.
In the positively reacting herds in which no enzootic
pneumonia either on clinical grounds or post mortem
examinations was found (n=17), usually 1 positive sample was
detected. In some herds there were also suspect samples. These
samples were clarified, following additional testing as false
positive singleton reactors. False positives were sometimes
positive also in the second, follow-up collection. Singleton
reactors of this sort present on 3 farms repeatedly gave positive
results in the ELISA.
In one disease-free herd, 10 out of 19 swine were positive in
the ELISA antibody tests. This herd had been recently formed
and consisted of gilts that had farrowed for the first time.
However, no enzootic pneumonia or M. hyopneumoniae
antibodies were detected in the offspring. It was therefore
concluded that the sows had had M. hyopneumoniae infection
previously but had already recovered before their farrowing adn
were no longer infectious. The positive reactions were thus  old
positive titers of recovered individuals. Thereafter the herd has
since remained M. hyopneumoniae free.
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4.11 A. pleuropneumoniae serotype 12 survey
More than 70% of the sows in 154 herds were tested. Of the
herds, 25 were totally free of sows with  A. pleuropneumoniae
serotype antibodies. In 31 herds 1-10% of the colostral samples
tested were positive, in 76 herds 11-50% of the sows had
antibodies, and in 22 herds more than half of the sows were
positive. The number of colostrum samples tested was 5,477, of
which 1307 were positive.
The herds in which the sows did not have A.
pleuropneumoniae antibodies were smaller (mean number of
sows 21, SD ±9) than the herds in which more than 50% of the
sows had antibodies in their colostra (mean number of sows 25,
SD ±14). No difference in the age of the sows or breed (large
white or landrace) were detected.
Clinical signs typical of A. pleuropneumoniae infection were
rare in all the herds investigated. During this study chronic
pleuritis was a problem in two disease-control herds. However, A.
pleuropneumoniae was not isolated either of  these outbreaks. In
these herds, 16% and 25% of the sows had A.
pleuropneumoniae serotype 2 antibodies in their colostrum. In
one of the seven progeny testing stations, there was an A.
pleuropneumoniae serotype 2 epidemic, indicating that
subclinical infections do in fact exist, as these stations only admit
piglets from disease control herds.
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4.12 A. pleuropneumoniae 12 serotypes
In the serum samples collected from slaughter sows, antibodies
against all serotypes of A. pleuropneumoniae were found. The
proportions of positives for each serrotype were as follows:
serotype 1, 7%, serotype 2, 26%, serotype 3, 51%, serotype 4,
8%, serotype 5, 1%, serotype 6, 2%, serotype 7, 6%, serotype 8,
1%, serotype 9, 8%, serotype10, 1%, serotype 11, 3% and
serotype 12, 10%.
The number of negative samples was 251. Altogether 229
samples had antibodies against one A. pleuropneumoniae
serotype, and 195 samples had antibodies against two or more
serotypes. In the case of serotypes 5, 6, 8, and 9, no samples
were found which reacted with these serotypes alone.
The pattern of distribution of A. pleuropneumoniae
serotypes varied throughout Finland. Serotype 1, serotype 9 and
serotype 12 antibodies were found most frequently in herds in the
western part of the country (p<0.001). Serotype 3 was found
most frequently in the south-west (p<0.001) and serotypes 4 and
6 in central Finland  (p<0.001). Antibodies against serotype 2,
which was the serotype most often isolated in acute epidemics,
were distributed evenly in herds throughout the country. In the
case of serotype 11, there were too few positive sera to
statistically assas the distribution of infected herds.
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4.13 Anti-PMT survey
The number of samples tested for anti-PMT antibodies was
5,650, and the number of herds tested was 188. Of the samples,
5,628 were negative and 22 were positive. Both toxigenic P.
multocida infection and progressive atrophic rhinitis (PAR) was
found in one herd.
Positive samples were found in 12 herds. In follow-up
studies including confirmatory testing one truly infected herd,
containing 11 seropositive animals, was found. Clinical signs of
PAR, i.e. sneezing, deviation of the snout and retarded growth,
were present. Toxigenic P. multocida was isolated from 11 of 29
nasal swabs taken from piglets. In this case  the source of
infection was identified as a consigment of pigs imported from a
herd knoen to be infected.
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5. Discussion
5.1 M. hyopneumoniae infections in disease-
control herds
The herds included in this study were disease- control herds and
were therefore expected to be free of M. hyopneumoniae.
However, six infected herds were found among the 185 herds
examined. In two of these herds the infection originated from the
same source; in the other four herds the infection route was
unknown. The diagnostic methods used were not capable of
indicating if these herds had been subclinically infected for a
longer period of time. The disease was usually introduced into a
herd through the purchase of new breeding animals.
Prior to this study, one or two herds in the disease-control
program had been diagnosed as suffering from enzootic
pneumonia each year  (Prof. A. Schulman personal
communication). More M. hyopneumoniae outbreaks were
identified by means of the new ELISA methods. This was
apparently due to the use of a  more sensitive diagnostic method.
Some of the cases detected might have been due to subclinical
infections, because some of the  outbreaks had earlier been
diagnosed at progeny testing stations which take piglets only from
disease-control herds. Nevertheless, the small number of infected
herds identified demonstrates that subclinical M.hyopneumoniae
infections are not widely spread among the herds controlled under
the Finnish Pig Health Scheme.
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M. hyopneumoniae infections are considered to be the most
widespread lung infection in pigs (Nicolet 1992). In the United
States, a study of slaughter swine revealed  that 99% of the herds
had pigs with pneumonic lesions, and a study of CF antibodies in
breeding herds indicated that 60% of the herds were affected
(Ross 1992). In Finland, however, the prevalence of this disease
has been low: with levels of 8% in south-western Finland and
30% in western Finland being recorded (Rautiainen 1998,
Tuovinen et al. 1994a).
Antibody assays on colostrum facilitates the earlier
diagnosis of mycoplasmal pneumonia in herds. During the survey
(I), an increase of antibodies was observed in three of the five
herds affected before there was any report of clinical signs or
pathological changes.  The interval from the introduction of M.
hyopneumoniae into a herd to the onset of clinical signs can be
as long as half a year, and even two years (Goodwin 1984). Rapid
detection of the infection facilitates eradication, and transmission
to other herds can also be prevented by this means.
Enzootic pneumonia is not fatal but the disease does retard
the growth of pigs. Samples for M. hyopneumoniae culture,
immunofluorescence or PCR, and routine pathological
examination, can be obtained from a few pigs; however the
methods are not sensitive enough for diagnostic purposes.
Serology appears to be the most effective method of detecting
enzootic pneumonia in living pigs, and the collection of samples is
easy. Blood samples can be taken from the selected animals and,
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also by measuring antibodies in colostra, the infection status of
the herd can be determined.
5.2 Specificity and sensitivity of the M.
hyopneumoniae ELISA 
Crude M. hyopneumoniae antigens have been described as
having a limited specificity (Armstrong et al. 1983, Feldt et al.
1992). In this study, however, reactions which could have been
due to cross-reactivity between different porcine mycoplasmas,
were not numerous among  the field material of over 6000
samples. The number of positive-reacting pigs in herds without a
disease background was 23. These animals were mostly false
positive singleton reactors found on individual farms. Infection by
any mycoplasma spp. would likely have resulted in several
antibody positive individuals in any herd.
Thus cross-reactions are possible among mycoplasmas, and
were found in ELISA tests carried out on hyperimmune sera
obtained from immunised rabbits. The strong, inactivated
mycoplasma suspensions used for immunisation also contained
common antigenic determinants. Repeated boostering of test
animals resulted in a strong immune response  to both  specific
and shared antigens. The phenomenon is less evident in natural
infection were antibodies are directed strongly against specific
surface epitopes. In ELISA assays, field sera or colostra can be
diluted in order to minimise cross-reactions to common antigens,
while specific reactions are still measurable at the higher dilutions.
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Tween 20 solubilised crude antigen, as used in the
Chekit®Hyoptest, has been shown to be more specific than other
crude antigens  (Nicolet et al. 1980, Bereiter et al. 1990,
Armstrong 1994). Cross-reactions with the related, mainly
apathogenic M. flocculare have been reported (Nicolet 1988). In
other studies these cross-reactions have not been marked
(Bereiter et al. 1990). Our results were identical to the latter study.
The construction of DAKO M. hyopneumoniae ELISA is
more complicated than that of Chekit®Hyoptest. The plates are
coated with rabbit antiserum to M. hyopneumoniae, and the M.
hyopneumoniae antigen is attached to this antiserum (Feldt et al.
1992). In the next step, samples compete with a monoclonal
antibody to M. hyopneumoniae. The results of study (II) imply
that DAKO M. hyopneumoniae ELISA may be more specific
than the more simply structured Chekit®Hyoptest. Both tests had
a high apparent specificity (DAKO M. hyopneumoniae ELISA,
99,3%, Chekit®Hyoptest, 98%) and they were therefore
appropriate for M. hyopneumoniae serology as part of the
disease control program.
In order to be of use in a disease-control program, a
serological test should clarify all the infected herds which are
cabable of spreading the disease further. Thus 100% sensitivity at
the herd level is required. In study (I), the sensitivity of the
Chekit®Hyoptest at the herd level was only 66,7%. All the
infected herds could have been found if the suspect samples had
been classified as containing specific antibodies (I). In the
infected herds (I) where no clear positive samples were found, the
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number of suspicious samples was 3 and 5. In the negative herds
all the samples were consistently negative. Suspect samples
always evoke  doubts in the minds of skilled laboratory
personnel,  and the herd of origin will be retested and examined
further  for clinical signs. A different the cut-off point would have
made the test more sensitive. As a result of this study, M.
hyopneumoniae ELISA had been  routinely used as a diagnostic
method in the disease-control program, and the cut-off point used
in the Chekit®Hyoptest  was changed.
While 100% sensitivity at the herd level is to object, all
diseased animals, however, cannot be found. ELISA’s are
essentially herd tests by nature. When testing individual animals,
these tests do not give a reliable indication of the current
infectious status of the individual or herd. All animals in an
infected herd do not necessarily become infected by M.
hyopneumoniae. Furthermore, antibody production in infected
animals  can be slow or even below the detectable level. Finally,
once developed, M. hyopneumoniae antibodies persist over
several farrowings, although the animals have already recovered.
Therefore, assesment of   the M. hyopneumoniae infectious
status by measuring antibodies from a single animal alone, is not
reliable.
The percentage of seropositive animals in the M.
hyopneumoniae infected herds (I) was low, an 11%. This was
probably related to the early phase of infection at the time of
sampling. Sanitation procedures were introduced immediately
after the serological diagnosis was confirmed by clinical and
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pathological findings. Therefore, there was no time for  most of
the sows to develop antibodies. In  study (II), in one herd
infected by M. hyopneumoniae only one positive sample was
found. Therefore singleton reactors cannot be automatically
judged as false positives, but the sample and the entire herd need
to be investigated further. In study (II) the DAKO M.
hyopneumoniae ELISA identified more positive animals (70/153)
than the Chekit®Hyoptest (30/153), and thus was more sensitive.
5.3  An exceptional herd in the M. hyopneumoniae
survey
An exceptional herd was found in  study (I). In this herd  M.
hyopneumoniae antibodies were found in 10 of 19 colostra tested
(53%). Despite the high number of positive animals, no clinical
signs were detected and no pneumonic lesions were found at post
mortem examination. The colostral antibody status of the herd
was further investigated by repeated sampling.  Because the anti-
body titre gradually declined, and no new infected animals were
found, there was no need to initiate restocking procedures. This
herd had recently been restocked with purchased animals. The
sows had obviously overcome the infection before the birth of the
offspring. It has been reported that small herds of up to 12 sows
can spontaneously recover from M. hyopneumoniae infection
(Waldman and Radtke 1937); however in larger herds there is
always a susceptible population present which is cabable of
carrying over the pathogen to the next generation.
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5.4 The A. pleuropneumoniae serotype 2 survey
(III)
According to this study, A. pleuropneumoniae serotype 2
appears to be widely spread in the herds in Finnish Pig Health
Scheme. Acute epidemics have nevertheless been rare. Only one
or two herds annually have been slaughtered as a result of acute
contagious pleuropneumonia. Despite this,  an unexpectedly large
number of A. pleuropneumoniae serotype 2 antibody positive
herds was found: most of the disease control herds included
sows thet were sero-positive, suggesting exposure to this
pathogwn.
Compared with other surveys, these results are not
particularly surprising. Other studies also support the finding that
A. pleuropneumoniae is much more widely spread than the acute
disease it causes (Brandrecht and Smith 1987, Elbers et al. 1990,
Larsen et al. 1990, Lariviere et al. 1990). Commercial piglet-
producing herds in south-western Finland also generally have
sows with A. pleuropneumoniae serotype 2 antibodies (Tuovinen
et al. 1994a). This suggests that serotype 2 is not always highly
virulent. Variations in virulence between strains of different
serotypes of A. pleuropneumoniae have been reported (Komal
and Mittal 1990, Møller et al. 1992). The virulence of different
serotypes also seems to vary geographically. In Denmark,
serotype 2 infections are usually acute, although subclinical
infections have also been detected (Nielsen 1988, Møller et al.
1992). Serotype 2 is the most prevalent serotype in Sweden but,
but acute epidemics are rare (Beskow et al. 1989). The rearing
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conditions in the Finnish breeding farms are very good, and as M.
hyopneumoniae infections are rare, these conditions may reduce
the likelihood of acute infections caused by A. pleuropneumoniae
serotype 2 (Ross 1992).
Only 25 disease-control herds appeared to be free of A.
pleuropneumoniae serotype 2 antibodies. Some of these herds
were very small closed herds, but there was no statistical
difference between the size of the most infected herds and the
clean herds. It has been reported that the number of seropositive
animals is not reflected enter of in the clinical signs (Nielsen 1988,
Zimmermann et al. 1990). In our study, however, the herds which
had more than 50% positive colostra also had pneumonic
symptoms, although A. pleuropneumoniae was not cultivated. In
this study we found 30 herds in which 1-10% of the animals were
positive. These reactions may have been false positives, but it is
also possible that they represented reactions to some earlier,
already eliminated infections.
According to the results of this study, the control of A.
pleuropneumoniae infections in the Finnish Pig Health Scheme
herds appears to be cumbersome. Because most of the herds
have A. pleuropneumoniae serotype antibodies without any
clinical problems, it is apparently not necessary to require
complete freedom from this infection. There have been no
records of breeding animals transferring clinical infectious
pleuritis to new herds. Infections in progeny testing stations give
rise to problems, and more knowledge is needed regarding the
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pathogenesis and epidemiology of A. pleuropneumoniae, in order
to control this infection in the Finnish Pig Health Scheme.
The prevalence of pleuritis as seen at meat inspection
does not necessarily reflect the level of  A. pleuropneumoniae
infection the herd in question, because pleuritis can have
multifactorial causes. Sample size should also be taken into
account when interpreting slaughterhouse data (Martin et al. 1987,
Pointon et al. 1990). Therefore, slaughter checks, as applied in the
Finnish Pig Health Scheme are not a reliable means of determining
the A. pleuropneumoniae status of a herd.
The control of A. pleuropneumoniae related disease might be
more effective if the diagnostic tests and vaccinations were
directed against  virulence factors instead of serotypes (Kamp et
al. 1994). However, there is not enough information about the
nature of virulence factors involved and their occurence in field
strains. Capsular polysaccharides, lipopolysaccharides and Apx
toxins (hemolysins and cytotoxins) have been suggested to play a
role in virulence (Komal and Mittal 1990). Ribotyping has been
introduced as a tool in epidemiological studies (Fussing et al.
1998),  but its discrimination power has been low.
5.5 A. pleuropneumoniae 12 serotypes survey (IV)
Serological reactions to serotype 3 were the most prevalent in this
survey, as more than half of the samples had serotype 3
antibodies. The number of positive samples was again relatively
high compared to the occurrence of acute pleuropneumonia.
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Serotype 3 has been known to be present on pig farms in Finland
(Dr A.Schulman personal communication), but it has not caused
acute epidemics. This is typical for serotype 3 strains, which have
previously been reported to cause only subclinical  or mild
infections  (Nielsen 1982, Nicolet 1992, Møller et al. 1992, Beck
et al . 1994).
The second most common serotype of A. pleuropneumoniae
appeared to be the serotype 2. The proportion of A.
pleuropneumoniae serotype 2 positive sera was 26% in slaughter
sows.  This is in good agreement with the serotype 2 survey
based on sow colostrum (III) and with the result of an earliera
survey in pig herds in south-western Finland (Tuovinen et al.
1994a). 24% of the sows in the Finnish Pig Health Scheme herds
had serotype 2 antibodies, as did 20 % of the sows in south-
western Finland. The number of seropositive animals reported
here is higher than would have been expected according to the
prevalence of clinical A. pleuropneumoniae manifestations. This
again reflects to the differences in pathogenicity among A.
pleuropneumoniae strains.
Many of the samples examined, 25% of the total number, had
antibodies against more than one A. pleuropneumoniae serotype.
This distribution has also been reported previously (Nielsen
1988). Because natural infection with one serotype may elicit
some cross-immunity to all other serotypes, new serotypes can
spread with low clinical morbidity in a chronically infected herd
(Nielsen 1982, Nielsen 1988, Van Haesebrouk et al. 1996).
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The pattern og distribution of serotypes in a particular area
must be known if disease control measures are to be planned
successfully. The vaccines which are currently available afford
protection only against the infection by the homologous serotype
(De Jong 1978, Nicolet 1992). Commercially available vaccines
reduce mortality, but do not prevent the carrier state developing
(Andresen 1997, Chiers et al. 1998, Furesz et al. 1998). Cross-
serovar protection can be achieved by the latest  mutant  vaccine
strains (Prideaux et al. 1999).
 According to the ELISA results, the most prevalent serotypes
in Finland are 2 and 3. At the present time, disease control in
Finland should be targeted towards these serotypes. However,
antibodies against serotypes 1, 9 and 12 have been found in
increased numbers in western Finland, as well as antibodies
against serotypes 4 and 6 in central districts. The serotype pattern
of A. pleuropneumoniae tends to change over the course of time
(Nielsen 1988). The antibody ELISA can be used to follow
changes and to identify the serotypes which may play a role as
important pathogens in the future.
5.6 The A. pleuropneumoniae ELISA
ELISA was chosen as a serological method for this study
because of its reported specificity and sensitivity (Nicolet 1981).
ELISA is a much more sensitive method than the widely used
complement fixation test (CF)  (Nicolet et al. 1981, Nielsen et al.
1991).
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The antigen used in this study was purified by phenol
extraction, which removes contaminating proteins, leaving only
the highly serotype-specific capsular polysaccharide (Bossé et al.
1990, Thwaits and Kadis 1991, Radacovici  et al. 1995).
In bacterialogical serology several Gram-negative bacteria
have been shown to share common antigens (Devenish et al.
1989). Likewise, cross-reactions have also caused problems in A.
pleuropneumoniae serology and serotyping (Nicolet 1992), and
therefore, purification of the antigen is very important.
Antigenic cross-reactions have been reported between A.
pleuropneumoniae serotypes 1, 9, 11 and 3, 6, 8 and 4, 7
(Nielsen 1985a, Nielsen 1985b, Mittal 1990, Gutierrez et al. 1991,
Nicolet 1992). The ELISA used in this study showed cross-
reactions between serotypes 1, 9, 11 and 6, 8 when tested with
rabbit antisera. However, when  testing the samples collected
from slaughter sowswere tested, cross-reactions were found
between the serotypes 9, 11 and 1, 2 and 9, 12. These results are
contradictory and it is therefore suggested that cross-reactions
between serotypes 1, 2 and 9, 12 might be due, in each case,  to
infections with both of these serotypes. Parallel infections with
several serotypes of A. pleuropneumoniae is known to occur
(Nielsen 1988). While phenol extraction removes cross-reacting
proteins there are a number of structural similarities among
lipopolysaccharide O antigens of A. pleuropneumoniae capsular
serotypes 1, 9 and 11 (Beynon et al. 1992), which may explain
this occurence.
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5.7 Progressive atrophic rhinitis (PAR) survey
The majority of epidemiological studies performed on PAR have
compared herds with and without a history of the clinical disease.
Serological surveys of PMT antibodies have not been carried out
in these herds prior  this study.
According to the ELISA assays, the Finnish Pig Health
Scheme herds were free of sows with antibodies to P. multocida
toxin (PMT). These results were in agreement with the clinical
surveys and  laboratory tests carried out on the isolated bacterial
strains. During 1984-1991, 125 P. multocida strains were isolated
from 103 pig herds including disease-contol and and conventional
herds that had suffered from respiratory infections:  only two of
the isolates produced toxin. The ELISA revealed only one PAR
positive swine herd: this herd had imported pigs from abroad.
The herd of origin had a disease free status at the time of
export, but had developed PAR again soon after selling pigs to
Finland. This export had been conducted without close veterinary
supervision. Periods of subclinical appearance are typical of
herds chronically infected with  toxigenic P. multocida.
Complementary monitoring of a herd for at least 2 years, based
on bacteriological and/or serological detection of the PAR-
toxigenic P. multocida, may be necessary in order to obtain
sufficient information concerning the true PAR-infected or PAR-
free status of the herd (De Jong 1992, Matschullat, G. et al. 1994).
The herds in the Finnish Pig Health Scheme were monitored for
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two years after this study and no new cases of PAR appeared in
the disease-control herds.
5.8 Specificity and sensitivity of the blocking
ELISA
The serological blocking ELISA was developed from
commercial kit for the detection of PM toxin. Both monoclonal
and polyclonal antibodies, which recognise different antigenic
epitopes of PMT, were used in the ELISA. Due to the cdesign of
the anti PMT- ELISA excellent specificity was to be expected.
The results of the study (V) confirm the expectations.
One disadvantage of the test was that contaminated and
otherwise spoiled colostrum samples produced weak positive
reactions. A considerably high number of spoiled samples was
found, 453 out of 5,650. Spoilage of the samples was easily
detected, and these samples were excluded  on the basis of foul
smell and coagulation. As could be expected, the spoiled colostra
were obtained during the summer months. Nine of the farms from
which fetid samples were sent were visited, and it was obvious
that the only possible explanation for the weak positive reactions
was the spoilage of the samples. Colostra of good quality
provided an  excellent sample for the ELISA PAR antibody
assay. The M. hyopneumoniae and A. pleuropneumoniae
ELISAs did not react  with the spoiled samples in the same way.
Infection with toxigenic P. multocida leads to a weak
systemic immune response (Chanter and Rutter 1989), and it may
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take up to three months before anti-PMT antibodies reach
detectable levels (Bording et al. 1992). Therefore one aim of this
study was to determine if P. multocida infections could be
detected for assaying antibodies. The results of this study
showed that, like several other serological tests used for the
detection of swine respiratory infections, the ELISA for PMT
antibodies is not able to classify individual animals into a positive
or negative disease status category, but can be used as a herd test
for identifying  infected herds (Stokes et Bourne 1989). When the
anti-PMT-ELISA is used as a herd test, the presence of animals
with high and low antibody titres indicates that the herd is infected
with P. multocida. Toxigenic  P. multocida  is maintained in a pig
herd by a small population of breeding females (De Jong 1992),
and, therefore, infection within a herd is best be detected by
assaying sows as a group.
5.9 Colostrum sample
Sow colostrum is an ideal sample for antibody assay. IgG is
concentrated in the colostrum and, for 24 h from the beginning of
farrowing, more IgG is found in colostrum than in serum (Nicolet
1988, Stokes and Bourne 1989). More positive animals in a herd
are found when colostrum samples are assayed compared to
serum samples (Nicolet 1988, Sørensen et al. 1993).
In testing the repeatability of  the Chekit®Hyoptest, it was
noted that a smaller number of positive samples was found in the
second assay. After recurrent freezing and thawing, samples tend
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to show less reactivity in antibody ELISA’s. On the other han
assay of colostrum only partly corrected this problem.
The collection of a colostrum sample causes very little
disstress to the sow. The farmer can collect the samples himself.
However, there are some risks involved when the herd owner
takes the samples for disease control. For example, the same sow
can be sampled  in error several times, or  the samples can be
taken too late after  farrowing. The Finnish Pig Health Scheme is a
voluntary disease control program. The owners of the herds
participating in the scheme are highly  motivated to do their best
in regard to  disease control, so as to provide the best pig
breeding material and healthy animals.
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6. Conclusions
1. Commercially available ELISAs for detecting M.
hyopneumoniae antibodies are sufficiently specific and sensitive
for the diagnosis of  M. hyopneumoniae infection within the
scope of a disease-control program. The DAKO M.
hyopneumoniae ELISA is more sensitive and specific. Using
both tests singleton positive reactions could be verified.
2. An ELISA for detecting antibodies to 12 serotypes of A.
pleuropneumoniae was developed. The test clearly distinguished
between positive and negative control sera, and positive and
negative field samples. The repeatability of the test was good.
However, the following cross-reactions between serotypes were
detected: 1, 9 and 11, 6 and 8, also  serotype 5(a) antiserum also
reacted with serotype 6 antigen. When the field samples collected
for this survey were examined, different cross-reactions were
found; the OD values of the samples reacting with serotypes 9
and 11, 9 and 12, and 1 and 2 correlated (p<0.01).
3. The ELISA test for detecting P. multocida toxin was modified
to detect antibody against PMT. A preincubation step was added
in which the samples were allowed to react with PMT  in case
there were PMT antibodies in the sample. Antibodies in the
samples blocked the binding of HRP-conjugate to the toxin. The
specificity of the test was calculated to be 99.8%. At the herd
level, the sensitivity was 100%. In the one infected herd the PMT-
antibody ELISA found  52% of the sow colostra to be  positive.
Because the actual number of seroconverted animals in the herd
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was not known, the sensitivity for individual samples was at least
52%. In comparison, the recovery rate of  toxigenic P. multocida
bacterium from nasal swab samples was 55%. Spoiled colostrum
samples characterised by a foul odour interfered with  the test and
gave false positive reactions. Good quality colostrum is to be
regarded a satisfactory sample in the PMT-antibody assay.
4. Colostrum from sows in the 185 top breeding herds, which
should have been M. hyopneumoniae free, were collected during
a half year period. Altogether 6,256 samples were received. A
total of  61  positive or suspect samples were found in 23 herds,
of which six herds were found to be truly M. hyopneumoniae
infected. The prevalence of M. hyopneumoniae in this group was
therefore 3.2%. The  proportion of positive and suspicious
samples in the affected herds averaged 18.2%.
A. pleuropneumoniae serotype 2 antibodies were
tested in pigs in 154 herds. Of the herds, 25 were totally free of A.
pleuropneumoniae serotype 2 antibodies. In 31 herds 1-10% of
the samples tested were positive, in 76 herds, 11-50% of the sows
had antibodies, and in 22 herds more than half of the sows were
positive. The number of colostrum samples tested was 5,477 and
1307 samples were positive. In one of the seven progeny testing
stations, which take piglets only from the disease-control herds,
there was an A. pleuropneumoniae serotype 2 epidemic,
indicating that subclinical infections can occur under such
conditions.
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188 herds were tested for PMT antibodies. Of the 5,650 samples
examined, 5,628 were negative and 22 were positive. Toxigenic P.
multocida infection, progressive atrophic rhinitis (PAR), was
confirmed in one herd.
5. In the samples collected from slaughter sows (n=675)  are
proportionally representing the different regions of Finland,
antibodies were found against all 12 serotypes of A.
pleuropneumoniae. The proportions of positive sera for each
serotype were as follows: serotype 1, 7%, serotype 2, 26%,
serotype 3, 51%, serotype 4, 8%, serotype 5, 1%, serotype 6,
2%, serotype 7, 6%, serotype 8, 1%, serotype 9, 8%, serotype
10, 1% serotype 11, 3% and serotype 12, 10%. The number of
negative samples was 251. Altogether 229 samples had antibodies
against one A. pleuropneumoniae serotype, and 195 samples had
antibodies against two or more A. pleuropneumoniae serotypes.
The serotype pattern of A. pleuropneumoniae varied
throughout Finland. Serotype 1, serotype 9 and serotype 12
antibodies were found most frequently in the western part of the
country (p<0.001). In the case of serotype 11, there were too few
positive reactions to test differences.  Serotype 3 was found most
frequently in the south-west (p<0.001) and serotype 4 and
serotype 6 antibodies in central Finland (p<0.001). Antibodies
against serotype 2, the serotype most often isolated in acute
epidemics, were evenly distributed throughout the country.
6. The M. hyopneumoniae antibody assay on colostrum
appeared to work well in disease-control programs. The
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laboratory test was sensitive and specific, the collection of
samples was easy and, by assaying for antibodies, more infected
herds were found and the diagnosis was estabished earlier than by
traditional methods.
The serological test for A. pleuropneumoniae appeared to be
sensitive and specific, but the disease situation concerning A.
pleuropneumoniae infection was worse and different to that
expected. The ELISA test could be used as a diagnostic tool in
disease cases but, due to the vast prevalence of subclinical A.
pleuropneumoniae infections, disease surveillance by serology is
not a reasonable measure.
The ELISA for P. multocida toxin antibodies is suitable for
disease-control purposes. However, because of the very low
prevalence of toxigenic P. multocida infections in Finnish Pig
Health Scheme herds, the cost effectiveness of continuing
surveillance by this or other means should first be evaluated.
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